Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Picardi

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Pharmacological Research|July 11, 2014
Novel prospects of statins as therapeutic agents in cancerSimona Pisanti, Paola Picardi, Elena Ciaglia, et al.
Trends in Pharmacological Sciences|April 23, 2013
The endocannabinoid signaling system in cancerSimona Pisanti, Paola Picardi, Alba D'Alessandro, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 8, 2017
Three-Dimensional Control of Ion Channel Function through Optogenetics and Co-CultureViviana Agus, Paola Picardi, Loredana Redaelli, et al.
Biologics : Targets & Therapy|October 2, 2015
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemiaAnna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, et al.
Therapeutic Advances in Hematology|August 6, 2016
Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association dataAnna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, et al.
Expert Review of Hematology|June 3, 2016
Paving the way for new agents; is standard chemotherapy part of the treatment paradigm for chronic lymphocytic leukemia in the future?Anna Maria Frustaci, Marco Montillo, Paola Picardi, et al.
Expert Review of Hematology|September 3, 2013
High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and futureAlessandro Isidori, Pier Paolo Piccaluga, Federica Loscocco, et al.
BMC Cancer|December 17, 2014
Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cellsRaffaella Belvedere, Valentina Bizzarro, Ada Popolo, et al.
International Journal of Cancer|September 9, 2017
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell linesElena Ciaglia, Chiara Laezza, Mario Abate, et al.
Frontiers in Oncology|September 25, 2024
Management of infections for patient treated with ibrutinib in clinical practiceClaudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Pharmacological Research|July 11, 2014
Novel prospects of statins as therapeutic agents in cancerSimona Pisanti, Paola Picardi, Elena Ciaglia, et al.
Trends in Pharmacological Sciences|April 23, 2013
The endocannabinoid signaling system in cancerSimona Pisanti, Paola Picardi, Alba D'Alessandro, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 8, 2017
Three-Dimensional Control of Ion Channel Function through Optogenetics and Co-CultureViviana Agus, Paola Picardi, Loredana Redaelli, et al.
Biologics : Targets & Therapy|October 2, 2015
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemiaAnna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, et al.
Therapeutic Advances in Hematology|August 6, 2016
Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association dataAnna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, et al.
Expert Review of Hematology|June 3, 2016
Paving the way for new agents; is standard chemotherapy part of the treatment paradigm for chronic lymphocytic leukemia in the future?Anna Maria Frustaci, Marco Montillo, Paola Picardi, et al.
Expert Review of Hematology|September 3, 2013
High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and futureAlessandro Isidori, Pier Paolo Piccaluga, Federica Loscocco, et al.
BMC Cancer|December 17, 2014
Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cellsRaffaella Belvedere, Valentina Bizzarro, Ada Popolo, et al.
International Journal of Cancer|September 9, 2017
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell linesElena Ciaglia, Chiara Laezza, Mario Abate, et al.
Frontiers in Oncology|September 25, 2024
Management of infections for patient treated with ibrutinib in clinical practiceClaudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
Pageof 4